Stocktoria
Climb Bio, Inc. CLYM
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-08-10
Chart by TradingView
2/9
Piotroski F — financial health
18.7
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$67.9M | -$82.0M | -$40.3M | -$45.1M | -$35.7M |
| Net income | -$59.9M | -$73.9M | -$35.1M | -$45.2M | -$47.5M |
| Operating cash flow | -$54.4M | -$15.6M | -$20.6M | -$37.4M | -$36.1M |
| Free cash flow | -$54.5M | -$15.6M | — | — | — |
| Total assets | $167.7M | $217.2M | $110.5M | $135.0M | $173.2M |
| Total liabilities | $7.3M | $5.3M | $2.9M | $6.3M | $6.0M |
| Shareholders' equity | $160.5M | $211.9M | $107.6M | $128.7M | $167.2M |
| Ratios | |||||
| Return on assets | -35.7% | -34.0% | -31.8% | -33.5% | -27.4% |
| Return on equity | -37.3% | -34.9% | -32.6% | -35.2% | -28.4% |
| Current ratio | 15.16 | 31.41 | 38.92 | 22.04 | 24.58 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 217,300 | $1.5M |
| Point72 Asset Management, L.P. | 59,090 | $404,767 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 18.7 (safe)
- Working capital / assets 0.589
- Retained earnings / assets -1.727
- EBIT / assets -0.405
- Equity / liabilities 22.077
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001768446 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.